May 22, 2020
A rapid research report synthesising the evidence base on COVID-19 therapeutics was written and peer reviewed by leading experts in Australia.
The report, released by the Australian Academy of Science, answers the following question posed by Australian ministers the Hon Karen Andrews MP, Minister for Industry, Science and Technology, and the Hon Greg Hunt MP, Minister for Health:
What are the most promising COVID-19 therapeutics in development globally and nationally, and what are their mechanisms of action, their stage of development and their strengths and limitations?
The rapid response was prepared by the Rapid Research Information Forum.
The lead author was Professor Sharon Lewin AO, APPRISE lead investigator and Director of the Peter Doherty Institute for Infection and Immunity, a joint venture of the University of Melbourne and The Royal Melbourne Hospital.
APPRISE investigator Professor Steve Webb, Senior Staff Specialist in Intensive Care Medicine at Royal Perth Hospital and a Professor of Critical Care Research in the School of Public Health and Preventive Medicine at Monash University, was a peer-reviewer of the report.